Smart deals start with the right connections.
Access 800+ qualified LPs through CQ’s Investor Database.
Syncona Limited
Venture Capital Firm,Private Equity Firm
Syncona is a leading FTSE 250 healthcare company focused on creating, building, and scaling a portfolio of global leaders in life science. The firm aims to deliver transformational treatments to patients in innovative healthcare areas while generating superior risk-adjusted returns for shareholders.
Overview and Management
Establishment Year
2012
Mission
To extend and enhance human life by creating, building, and scaling companies that deliver transformational treatments in areas of high unmet medical need.
Values
Excellence, Entrepreneurial, Teamwork, Leadership, Data-Driven.
Investment Roles
General Partner (GP)
Participant Demographics
Focuses on treatments for patients with significant unmet needs, collaborating with academic founders and management teams.
Generational Wealth Planning
Risk Tolerance
Long-term view with a focus on innovative science and superior risk-adjusted returns.
References or Case Studies
The firm highlights portfolio companies and documented success stories, such as Autolus Therapeutics and Beacon Therapeutics.
Team Experience
92% of the investment team holds PhDs in life sciences
Notable Achievements
Portfolio IRR of 17% since 2012, successful exits such as the sale of Blue Earth Diagnostics for a 10x return
Project Track Record
Investments in companies like Autolus Therapeutics and Beacon Therapeutics
Exit Strategies
Strategic sales and public listings
Legal, Compliance and Contact Information
Regulatory Registrations
UN PRI, Net Zero Asset Managers Initiative
Compliance History
No major violations reported
contact@synconaltd.com
Phone Number
+44 (0) 20 3981 7912
Address
London United Kingdom